Allergic Bronchopulmonary Aspergillosis Clinical Trial
What is Allergic Bronchopulmonary Aspergillosis?
Allergic Bronchopulmonary Aspergillosis is a hypersensitive response of the immune system to a fungus species called Aspergillus. This allergic reaction causes inflammation in the lungs which primarily affects those with asthma or cystic fibrosis
About the Study
A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Itraconazole Administered as a Dry Powder for Inhalation (PUR1900) in adult asthmatic patients with Allergic Bronchopulmonary Aspergillosis (ABPA)
Compensation for Time and Travel
All study related visits, care, tests, and medication will be provided to participants at no cost. Reimbursement for time and travel may be provided. Please contact us for more information as compensation varies by each study
Who is Eligible to Participate?
- Individuals between 18 and 75 years of age
- Has a historical diagnosis of asthma and ABPA
- Satisfy all of the eligibility requirements
Please Call or Text our office at 407-574-5650 to learn more and book a no cost assessment with our Research Physicians.